Your Shopping Cart Is Empty
| Report Code: A12535 | Jul 2021 | Pages: 229 | ||
| Tables: 119 | Charts: 46 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Critical Care Nutrition Market
Request Now !The global critical care nutrition market size was valued at $10,618.96 million in 2020, and is projected to reach $19,237.81 million by 2030, registering a CAGR of 6.3% from 2021 to 2030.
The outbreak of the COVID-19 pandemic led to a massive economic growth due to its spread to masses, causing pneumonia due to the virus of COVID-19. It is a large family of viruses that causes illness ranging from common cold to more severe diseases.
Critical care nutrition offers the nutrition support therapy for critically ill patients to gain positive patient outcomes. Critical care is the provision for safer and appropriate nutrition, which needs to be provided to patients admitted in the ICU that requires evidence-based practice. The critical care nutritional therapy is approved to patients suffering from chronic illness such as gastrointestinal disorder and cancer. In addition, the nutrition therapy, if taken in early stages, may assist in decreasing the disease severity and reduce complications that are caused due to insufficiency of nutrition. Furthermore, decrease in length of stay in the ICU and decline in the rate of mortality in patient population, who have undergone early nutritional therapy are expected to support the market to generate higher revenue during the forecast period.
Surge in healthcare spending is likely to help the market gain traction during the forecast period. Moreover, increase in prevalence of chronic disorders such as cancer and neurological disorders is the major factor that contributes toward the growth of the global critical care nutrition market. According to the statistics given by the American Society of Clinical Oncology Journal in 2020, incidence rate of cancer was higher among females, which was about 712,758 than males, which was about 679,421 for the year 2020. The projected national cancer incidence burden in 2020 will be 98.7 per 100,000 population that is approximately 1,392,179 patients as a conservative estimate.
In addition, increase in geriatric population is expected to fuel the market growth. This is attributed to the fact aged individuals are highly susceptible to suffer from critical illness. According to the statistics given by the United Nations in 2020, the world ageing population is about 727 million who are aged 65 years and above across the globe, and is estimated to reach 1.5 billion by 2050. However, lack of awareness regarding critical care nutrition for patients admitted in the ICU in underdeveloped countries hinders the market growth.
On the contrary, the development of newer technologically advanced products and high market potential in untapped emerging economies are projected to provide lucrative opportunities for the growth of the critical care nutrition market.
The World Health Organization (WHO) on January 30, 2021 declared COVID-19 outbreak a public health emergency of international concern. The critical care nutrition can be used for assistance in various critical illnesses. Decreased hospital stays due to early nutrition therapy would help the market grow with the advent of COVID-19 during the forecast period. In addition, fulfillment of nutritional deficiencies through critical care nutrition is anticipated to help the market generate higher revenue during the forecast period.
The global critical care nutrition market is segmented into route of administration, application, age group, and region. On the basis of route of administration, the market is bifurcated into enteral and parenteral. The applications covered in the study include cancer, neurological diseases, gastrointestinal disorders, and others. Depending on age group, the market is segregated into pediatric, adults, geriatric. The pediatric segment is further divided into enteral and parenteral nutrition. Furthermore, the adults segment is categorized into enteral and parenteral. The geriatric segment is further fragmented into enteral and parenteral nutrition. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of route of administration, the enteral segment dominated the global critical care nutrition market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to advantages posed by the enteral route of administration, including improvement in gastrointestinal tract’s (GI) blood flow and improvement in GI mucosal health. In addition, minimal side effects caused due to enteral route of administration as compared to other mode of administration will help the segment generate higher revenue in the coming years.
Depending on application, the cancer segment dominated the global critical care nutrition market in 2020, and is anticipated to continue this trend in the future. This is attributable to surge in adoption of sedentary lifestyle leading to increase in prevalence of cancer.
On the basis of end user, the geriatric segment garnered majority of the share, owing to increase in number of patients suffering from chronic diseases such as diabetes, cancer, and gastrointestinal disorders. Furthermore, surge in geriatric population that requires critical care nutrition is expected to contribute to the critical care nutrition market growth.
List Of Key Companies
Key Benefits For Stakeholders
Key Market Segments
By Route of Administration
By Application
By End User
By Region
Critical Care Nutrition Market Report Highlights
| Aspects | Details |
|---|---|
| By ROUTE OF ADMINISTRATION |
|
| By APPLICATION |
|
| By AGE GROUP |
|
| By Region |
|
| Key Market Players | FRESENIUS KABI AKTIENGESELLSCHAFT, DANONE S.A., ABBOTT LABORATORIES, B. BRAUN MELSUNGEN AG, HORMEL FOODS CORPORATION, MEIJI HOLDINGS CO., LTD., NESTLE S.A., BAXTER INTERNATIONAL, INC., RECKITT BENCKISER GROUP PLC, VICTUS INC. |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Surge in healthcare spending for patient population
3.5.1.2.Increase in prevalence of ageing associated diseases
3.5.1.3.Rise in incidences of the targeted disease
3.5.1.4.Advantages offered by critical care nutrition
3.5.2.Restraints
3.5.2.1.Inadequate efficiency of nutritional care in critically ill patients
3.5.3.Opportunity
3.5.3.1.High market potential in emerging economies
3.5.4.Impact analysis
3.6.COVID-19 Impact Analysis on critical care nutrition Market
CHAPTER 4:CRITICAL CARE NUTRITION MARKET, BY ROUTE OF ADMINISTRATION
4.1.Overview
4.1.1.Market size and forecast
4.2.Enteral
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Parenteral
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
CHAPTER 5:CRITICAL CARE NUTRITION MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Cancer
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Neurological Diseases
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.3.3.Gastrointestinal Disorders
5.3.4.Market size and forecast, by region
5.3.5.Market analysis, by country
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:CRITICAL CARE NUTRITION MARKET, BY AGE GROUP
6.1.Overview
6.1.1.Market size and forecast
6.2.Pediatric
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by route of administration
6.3.Adults
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.3.3.Market size and forecast, by route of administration
6.4.Geriatric
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
6.4.3.Market size and forecast, by route of administration
CHAPTER 7:CRITICAL CARE NUTRITION MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America market size and forecast, by Route of administration
7.2.3.North America market size and forecast, by Application
7.2.4.North America market size and forecast, by age group
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.Critical care nutrition market, for U.S., by Route of administration
7.2.5.1.2.Critical care nutrition market, for U.S., by Application
7.2.5.1.3.Critical care nutrition market, for U.S., by age group
7.2.5.2.Canada
7.2.5.2.1.Critical care nutrition market, for Canada, by Route of administration
7.2.5.2.2.Critical care nutrition market, for Canada, by Application
7.2.5.2.3.Critical care nutrition market, for Canada, by age group
7.2.5.3.Mexico
7.2.5.3.1.Critical care nutrition market, for Mexico, by Route of administration
7.2.5.3.2.Critical care nutrition market, for Mexico, by Application
7.2.5.3.3.Critical care nutrition market, for Mexico, by age group
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe market size and forecast, by Route of administration
7.3.3.Europe market size and forecast, by Application
7.3.4.Europe market size and forecast, by age group
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Critical care nutrition market, for Germany, by Route of administration
7.3.5.1.2.Critical care nutrition market, for Germany, by Application
7.3.5.1.3.Critical care nutrition market, for Germany, by age group
7.3.5.2.France
7.3.5.2.1.Critical care nutrition market, for France, by Route of administration
7.3.5.2.2.Critical care nutrition market, for France, by Application
7.3.5.2.3.Critical care nutrition market, for France, by age group
7.3.5.3.UK
7.3.5.3.1.Critical care nutrition market, for UK, by Route of administration
7.3.5.3.2.Critical care nutrition market, for UK, by Application
7.3.5.3.3.Critical care nutrition market, for UK, by age group
7.3.5.4.Italy
7.3.5.4.1.Critical care nutrition market, for Italy, by Route of administration
7.3.5.4.2.Critical care nutrition market, for Italy, by Application
7.3.5.4.3.Critical care nutrition market, for Italy, by age group
7.3.5.5.Spain
7.3.5.5.1.Critical care nutrition market, for Spain, by Route of administration
7.3.5.5.2.Critical care nutrition market, for Spain, by Application
7.3.5.5.3.Critical care nutrition market, for Spain, by age group
7.3.5.6.Rest of Europe
7.3.5.6.1.Critical care nutrition market, for Rest of Europe, by Route of administration
7.3.5.6.2.Critical care nutrition market, for Rest of Europe, by Application
7.3.5.6.3.Critical care nutrition market, for Rest of Europe, by age group
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific market size and forecast, by Route of administration
7.4.3.Asia-Pacific market size and forecast, by Application
7.4.4.Asia-Pacific market size and forecast, by age group
7.4.5.Market size and forecast, by country
7.4.5.1.Japan
7.4.5.1.1.Critical care nutrition market, for Japan, by Route of administration
7.4.5.1.2.Critical care nutrition market, for Japan, by Application
7.4.5.1.3.Critical care nutrition market, for Japan, by age group
7.4.5.2.China
7.4.5.2.1.Critical care nutrition market, for China, by Route of administration
7.4.5.2.2.Critical care nutrition market, for China, by Application
7.4.5.2.3.Critical care nutrition market, for China, by age group
7.4.5.3.Australia
7.4.5.3.1.Critical care nutrition market, for Australia, by Route of administration
7.4.5.3.2.Critical care nutrition market, for Australia, by Application
7.4.5.3.3.Critical care nutrition market, for Australia, by age group
7.4.5.4.India
7.4.5.4.1.Critical care nutrition market, for India, by Route of administration
7.4.5.4.2.Critical care nutrition market, for India, by Application
7.4.5.4.3.Critical care nutrition market, for India, by age group
7.4.5.5.South Korea
7.4.5.5.1.Critical care nutrition market, for South Korea, by Route of administration
7.4.5.5.2.Critical care nutrition market, for South Korea, by Application
7.4.5.5.3.Critical care nutrition market, for South Korea, by age group
7.4.5.6.Rest of Asia-Pacific
7.4.5.6.1.Critical care nutrition market, for Rest of Asia-Pacific, by Route of administration
7.4.5.6.2.Critical care nutrition market, for Rest of Asia-Pacific, by Application
7.4.5.6.3.Critical care nutrition market, for Rest of Asia-Pacific, by age group
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA market size and forecast, by Route of administration
7.5.3.LAMEA market size and forecast, by Application
7.5.4.LAMEA market size and forecast, by age group
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil
7.5.5.1.1.Critical care nutrition market, for Brazil, by Route of administration
7.5.5.1.2.Critical care nutrition market, for Brazil, by Application
7.5.5.1.3.Critical care nutrition market, for Brazil, by age group
7.5.5.2.Saudi Arabia
7.5.5.2.1.Critical care nutrition market, for Saudi Arabia, by Route of administration
7.5.5.2.2.Critical care nutrition market, for Saudi Arabia, by Application
7.5.5.2.3.Critical care nutrition market, for Saudi Arabia, by age group
7.5.5.3.South Africa
7.5.5.3.1.Critical care nutrition market, for South Africa, by Route of administration
7.5.5.3.2.Critical care nutrition market, for South Africa, by Application
7.5.5.3.3.Critical care nutrition market, for South Africa, by age group
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Critical care nutrition market, for Rest of LAMEA, by Route of administration
7.5.5.4.2.Critical care nutrition market, for Rest of LAMEA, by Application
7.5.5.4.3.Critical care nutrition market, for Rest of LAMEA, by age group
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company overview
8.1.2.Company Snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.BAXTER INTERNATIONAL, INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.B. BRAUN MELSUNGEN AG
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.DANONE S.A.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.FRESENIUS KABI AKTIENGESELLSCHAFT
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.HORMEL FOODS CORPORATION
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.MEIJI HOLDINGS CO., LTD.
8.7.1.Company overview
8.7.2.Operating business segments
8.7.3.Product portfolio
8.7.4.Business performance
8.7.5.Key strategic moves and developments
8.8.NESTLE S.A.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.RECKITT BENCKISER GROUP PLC
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.VICTUS INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.CRITICAL CARE NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2020–2030 ($MILLION)
TABLE 02.CRITICAL CARE NUTRITION MARKET, FOR ENTERAL, BY REGION, 2020–2030 ($MILLION)
TABLE 03.CRITICAL CARE NUTRITION MARKET, FOR PARENTERAL, BY REGION, 2020–2030 ($MILLION)
TABLE 04.CRITICAL CARE NUTRITION MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 05.CRITICAL CARE NUTRITION MARKET, FOR CANCER, BY REGION, 2020–2030 ($MILLION)
TABLE 06.CRITICAL CARE NUTRITION MARKET, FOR NEUROLOGICAL DISEASES, BY REGION, 2020–2030 ($MILLION)
TABLE 07.CRITICAL CARE NUTRITION MARKET, FOR GASTROINTESTINAL DISORDERS, BY REGION, 2020–2030 ($MILLION)
TABLE 08.CRITICAL CARE NUTRITION MARKET, FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 09.CRITICAL CARE NUTRITION MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 10.CRITICAL CARE NUTRITION MARKET FOR PEDIATRIC, BY REGION, 2020–2030 ($MILLION)
TABLE 11.CRITICAL CARE NUTRITION MARKET FOR PEDIATRIC, BY ROUTE OF ADMINISTRATION, 2020–2030 ($MILLION)
TABLE 12.CRITICAL CARE NUTRITION MARKET FOR ADULTS, BY REGION, 2020–2030 ($MILLION)
TABLE 13.CRITICAL CARE NUTRITION MARKET FOR ADULTS, BY ROUTE OF ADMINISTRATION, 2020–2030 ($MILLION)
TABLE 14.CRITICAL CARE NUTRITION MARKET FOR GERIATRIC, BY REGION, 2020–2030 ($MILLION)
TABLE 15.CRITICAL CARE NUTRITION MARKET FOR GERIATRIC, BY ROUTE OF ADMINISTRATION, 2020–2030 ($MILLION)
TABLE 16.CRITICAL CARE NUTRITION MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17.CRITICAL CARE NUTRITION MARKET, FOR NORTH AMERICA, BY ROUTE OF ADMINISTRATION, 2020–2030, ($MILLION)
TABLE 18.CRITICAL CARE NUTRITION MARKET, FOR NORTH AMERICA, BY APPLICATION, 2020–2030, ($MILLION)
TABLE 19.CRITICAL CARE NUTRITION MARKET, FOR NORTH AMERICA, BY AGE GROUP, 2020–2030, ($MILLION)
TABLE 20.CRITICAL CARE NUTRITION MARKET, FOR NORTH AMERICA, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 21.CRITICAL CARE NUTRITION MARKET, FOR U.S., BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 22.CRITICAL CARE NUTRITION MARKET, FOR U.S., BY APPLICATION, 2020–2030
TABLE 23.CRITICAL CARE NUTRITION MARKET, FOR U.S., BY AGE GROUP, 2020–2030
TABLE 24.CRITICAL CARE NUTRITION MARKET, FOR CANADA, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 25.CRITICAL CARE NUTRITION MARKET, FOR CANADA, BY APPLICATION, 2020–2030
TABLE 26.CRITICAL CARE NUTRITION MARKET, FOR CANADA, BY AGE GROUP, 2020–2030
TABLE 27.CRITICAL CARE NUTRITION MARKET, FOR MEXICO, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 28.CRITICAL CARE NUTRITION MARKET, FOR MEXICO, BY APPLICATION, 2020–2030
TABLE 29.CRITICAL CARE NUTRITION MARKET, FOR MEXICO, BY AGE GROUP, 2020–2030
TABLE 30.CRITICAL CARE NUTRITION MARKET, FOR EUROPE, BY ROUTE OF ADMINISTRATION, 2020–2030, ($MILLION)
TABLE 31.CRITICAL CARE NUTRITION MARKET, FOR EUROPE, BY APPLICATION, 2020–2030, ($MILLION)
TABLE 32.CRITICAL CARE NUTRITION MARKET, FOR EUROPE, BY AGE GROUP, 2020–2030, ($MILLION)
TABLE 33.CRITICAL CARE NUTRITION MARKET, FOR EUROPE CRITICAL CARE NUTRITION MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 34.CRITICAL CARE NUTRITION MARKET, FOR GERMANY, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 35.CRITICAL CARE NUTRITION MARKET, FOR GERMANY, BY APPLICATION, 2020–2030
TABLE 36.CRITICAL CARE NUTRITION MARKET, FOR GERMANY, BY AGE GROUP, 2020–2030
TABLE 37.CRITICAL CARE NUTRITION MARKET, FOR FRANCE, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 38.CRITICAL CARE NUTRITION MARKET, FOR FRANCE, BY APPLICATION, 2020–2030
TABLE 39.CRITICAL CARE NUTRITION MARKET, FOR FRANCE, BY AGE GROUP, 2020–2030
TABLE 40.CRITICAL CARE NUTRITION MARKET, FOR UK, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 41.CRITICAL CARE NUTRITION MARKET, FOR UK, BY APPLICATION, 2020–2030
TABLE 42.CRITICAL CARE NUTRITION MARKET, FOR UK, BY AGE GROUP, 2020–2030
TABLE 43.CRITICAL CARE NUTRITION MARKET, FOR ITALY, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 44.CRITICAL CARE NUTRITION MARKET, FOR ITALY, BY APPLICATION, 2020–2030
TABLE 45.CRITICAL CARE NUTRITION MARKET, FOR ITALY, BY AGE GROUP, 2020–2030
TABLE 46.CRITICAL CARE NUTRITION MARKET, FOR SPAIN, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 47.CRITICAL CARE NUTRITION MARKET, FOR SPAIN, BY APPLICATION, 2020–2030
TABLE 48.CRITICAL CARE NUTRITION MARKET, FOR SPAIN, BY AGE GROUP, 2020–2030
TABLE 49.CRITICAL CARE NUTRITION MARKET, FOR REST OF EUROPE, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 50.CRITICAL CARE NUTRITION MARKET, FOR REST OF EUROPE, BY APPLICATION, 2020–2030
TABLE 51.CRITICAL CARE NUTRITION MARKET, FOR REST OF EUROPE, BY AGE GROUP, 2020–2030
TABLE 52.CRITICAL CARE NUTRITION MARKET, FOR ASIA-PACIFIC, BY ROUTE OF ADMINISTRATION, 2020–2030, ($MILLION)
TABLE 53.CRITICAL CARE NUTRITION MARKET, FOR ASIA-PACIFIC, BY APPLICATION, 2020–2030, ($MILLION)
TABLE 54.CRITICAL CARE NUTRITION MARKET, FOR ASIA-PACIFIC, BY AGE GROUP, 2020–2030, ($MILLION)
TABLE 55.CRITICAL CARE NUTRITION MARKET, FOR ASIA-PACIFIC , BY COUNTRY, 2020–2030 ($MILLION)
TABLE 56.CRITICAL CARE NUTRITION MARKET, FOR JAPAN, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 57.CRITICAL CARE NUTRITION MARKET, FOR JAPAN, BY APPLICATION, 2020–2030
TABLE 58.CRITICAL CARE NUTRITION MARKET, FOR JAPAN, BY AGE GROUP, 2020–2030
TABLE 59.CRITICAL CARE NUTRITION MARKET, FOR CHINA, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 60.CRITICAL CARE NUTRITION MARKET, FOR CHINA, BY APPLICATION, 2020–2030
TABLE 61.CRITICAL CARE NUTRITION MARKET, FOR CHINA, BY AGE GROUP, 2020–2030
TABLE 62.CRITICAL CARE NUTRITION MARKET, FOR AUSTRALIA, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 63.CRITICAL CARE NUTRITION MARKET, FOR AUSTRALIA, BY APPLICATION, 2020–2030
TABLE 64.CRITICAL CARE NUTRITION MARKET, FOR AUSTRALIA, BY AGE GROUP, 2020–2030
TABLE 65.CRITICAL CARE NUTRITION MARKET, FOR INDIA, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 66.CRITICAL CARE NUTRITION MARKET, FOR INDIA, BY APPLICATION, 2020–2030
TABLE 67.CRITICAL CARE NUTRITION MARKET, FOR INDIA, BY AGE GROUP, 2020–2030
TABLE 68.CRITICAL CARE NUTRITION MARKET, FOR SOUTH KOREA, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 69.CRITICAL CARE NUTRITION MARKET, FOR SOUTH KOREA, BY APPLICATION, 2020–2030
TABLE 70.CRITICAL CARE NUTRITION MARKET, FOR SOUTH KOREA, BY AGE GROUP, 2020–2030
TABLE 71.CRITICAL CARE NUTRITION MARKET, FOR REST OF ASIA-PACIFIC, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 72.CRITICAL CARE NUTRITION MARKET, FOR REST OF ASIA-PACIFIC, BY APPLICATION, 2020–2030
TABLE 73.CRITICAL CARE NUTRITION MARKET, FOR REST OF ASIA-PACIFIC, BY AGE GROUP, 2020–2030
TABLE 74.CRITICAL CARE NUTRITION MARKET, FOR LAMEA, BY ROUTE OF ADMINISTRATION, 2020–2030, ($MILLION)
TABLE 75.CRITICAL CARE NUTRITION MARKET, FOR LAMEA, BY APPLICATION, 2020–2030, ($MILLION)
TABLE 76.CRITICAL CARE NUTRITION MARKET, FOR LAMEA, BY AGE GROUP, 2020–2030, ($MILLION)
TABLE 77.CRITICAL CARE NUTRITION MARKET, FOR LAMEA, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 78.CRITICAL CARE NUTRITION MARKET, FOR BRAZIL, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 79.CRITICAL CARE NUTRITION MARKET, FOR BRAZIL, BY APPLICATION, 2020–2030
TABLE 80.CRITICAL CARE NUTRITION MARKET, FOR BRAZIL, BY AGE GROUP, 2020–2030
TABLE 81.CRITICAL CARE NUTRITION MARKET, FOR SAUDI ARABIA, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 82.CRITICAL CARE NUTRITION MARKET, FOR SAUDI ARABIA, BY APPLICATION, 2020–2030
TABLE 83.CRITICAL CARE NUTRITION MARKET, FOR SAUDI ARABIA, BY AGE GROUP, 2020–2030
TABLE 84.CRITICAL CARE NUTRITION MARKET, FOR SOUTH AFRICA, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 85.CRITICAL CARE NUTRITION MARKET, FOR SOUTH AFRICA, BY APPLICATION, 2020–2030
TABLE 86.CRITICAL CARE NUTRITION MARKET, FOR SOUTH AFRICA, BY AGE GROUP, 2020–2030
TABLE 87.CRITICAL CARE NUTRITION MARKET, FOR REST OF LAMEA, BY ROUTE OF ADMINISTRATION, 2020–2030
TABLE 88.CRITICAL CARE NUTRITION MARKET, FOR REST OF LAMEA, BY APPLICATION, 2020–2030
TABLE 89.CRITICAL CARE NUTRITION MARKET, FOR REST OF LAMEA, BY AGE GROUP, 2020–2030
TABLE 90.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 91.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 92.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 93.BAXTER: COMPANY SNAPSHOT
TABLE 94.BAXTER: OPERATING SEGMENTS
TABLE 95.BAXTER: PRODUCT PORTFOLIO
TABLE 96.B. BRAUN: COMPANY SNAPSHOT
TABLE 97.B. BRAUN: OPERATING SEGMENTS
TABLE 98.B. BRAUN: PRODUCT PORTFOLIO
TABLE 99.DANONE: COMPANY SNAPSHOT
TABLE 100.DANONE: OPERATING SEGMENTS
TABLE 101.DANONE: PRODUCT PORTFOLIO
TABLE 102.FRESENIUS KABI AG: COMPANY SNAPSHOT
TABLE 103.FRESENIUS KABI AG: OPERATING SEGMENTS
TABLE 104.FRESENIUS KABI AG: PRODUCT PORTFOLIO
TABLE 105.HORMEL FOODS : COMPANY SNAPSHOT
TABLE 106.HORMEL FOODS : OPERATING SEGMENTS
TABLE 107.HORMEL FOODS : PRODUCT PORTFOLIO
TABLE 108.MEIJI HOLDINGS: COMPANY SNAPSHOT
TABLE 109.MEIJI HOLDINGS: OPERATING SEGMENTS
TABLE 110.MEIJI HOLDINGS: PRODUCT PORTFOLIO
TABLE 111.NESTLE : COMPANY SNAPSHOT
TABLE 112.NESTLE : OPERATING SEGMENTS
TABLE 113.NESTLE: PRODUCT PORTFOLIO
TABLE 114.RECKITT: COMPANY SNAPSHOT
TABLE 115.RECKITT: OPERATING SEGMENTS
TABLE 116.RECKITT: PRODUCT PORTFOLIO
TABLE 117.VICTUS: COMPANY SNAPSHOT
TABLE 118.VICTUS: OPERATING SEGMENTS
TABLE 119.VICTUS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.CRITICAL CARE NUTRITION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.LOW BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, FOR ENTERAL, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, FOR PARENTERAL, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, FOR CANCER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, FOR GASTROINTESTINAL DISORDERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, FOR PEDIATRIC, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, ADULTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF CRITICAL CARE NUTRITION MARKET, GERIATRIC, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.ABBOTT LABORATORIES: REVENUE, 2018–2020 ($MILLION)
FIGURE 23.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24.ABBOTT LABORATORIES: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 25.BAXTER: REVENUE, 2018–2020 ($MILLION)
FIGURE 26.BAXTER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.BAXTER: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 28.B. BRAUN: REVENUE, 2020 (%)
FIGURE 29.B. BRAUN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30.DANONE: REVENUE, 2018–2020 ($MILLION)
FIGURE 31.DANONE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.DANONE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.FRESENIUS KABI AG: REVENUE, 2018–2020 ($MILLION)
FIGURE 34.FRESENIUS KABI AG: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.FRESENIUS KABI AG: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 36.HORMEL FOODS: REVENUE, 2018–2020 ($MILLION)
FIGURE 37.HORMEL FOODS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.HORMEL FOODS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39.MEIJI HOLDINGS: REVENUE, 2018-2020 ($MILLION)
FIGURE 40.MEIJI HOLDINGS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41.NESTLE: REVENUE, 2018–2020 ($MILLION)
FIGURE 42.NESTLE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.NESTLE: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 44.RECKITT: REVENUE, 2018-2020 ($MILLION)
FIGURE 45.RECKITT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46.RECKITT: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
Critical care nutrition is provision of safe and optimal nutrition that need to be provided to patients admitted to the ICU, using evidence based practice.
Increase in prevalence of conditions such as cancer, neurological diseases, and gastrointestinal diseases worldwide notbaly contributes toward the market growth. Furthermore, adoption of smoking, higher exposure to toxic materials, adverse climate conditions & air pollution, causing cancer will help the market gain traction during the forecast period. However, lack of awareness of critical care nutrition at early stages hinders the growth of the market.
North America is expected to remain dominant during the forecast period, owing to increase in demand for critical care nutrition, rise in incidence of cancer, and presence of major key players along with R&D centers in the region. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to increase in demand for critical care nutrition in the region along with higher adoption of sedentary lifestyle by the population.
A. Critical Care Nutrition is a therapy that is given for the indviduals suffering from critical illness and are admitted to intensive care units due to severity of the conidition.
A. Critical Care Nutrition are used when the healthcare professionals require assistance in providing nutritional therapy with required components to the patients admitted to intensive care units
A. The total value of Critical Care Nutrition market was $10,618.96 million in 2020.
A. The forecast period in the report is from 2021-2030.
A. The market value of Critical Care Nutrition market in 2030 was $19,237.81 million.
A. The base year calculated in the report is 2020.
A. Increased demand for the Critical Care Nutrition for decreasing the duration of stays in hospitals and rise in admissions to ICUs will drive the market over the near future according to the KOLs.
A. The market has drawn the interest of the healthcare industry, owing to increasing prevalence of cardiovascular diseases, rise in product launches of Critical Care Nutrition, and growing awareness among healthcare professionals regarding Critical Care Nutrition
A. By route of administration, the enteral segment holds the maximum market share.
A. The market in Asia-Pacific is expected to register lucrative CAGR of 7.4% over the forecast period owing to presence of large population base, increase in awareness regarding Critical Care Nutrition, and rise in disposable income
Start reading instantly.
This Report and over 66,965+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report